AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Is the FDA Too Cautious?
Open to Debate
The FDA's Precautionary Approach to Drug Approval
Peter Lorry: FDA at this point is more or less gotten at right, and you'll hear some criticisms from me. But when we talk about caution, let's at least unpack the question. Are we talking about caution as in too fast or not fast enough? And I would submit that FDA is not too cautious with respect to either of these.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode